AnaptysBio clears an early hurdle in low-stress PoC study for peanut allergy med -- big questions go unanswered
AnaptysBio $ANAB got a big boost out of some early and positive results for its peanut allergy med ANB020. It was a small, short study …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
